Tom Abrams’ Steady Leadership Guided US FDA Through Dramatic Changes In Rx Promotion

 
• By Brenda Sandburg
  
Time - Abstract illustration
FDA's Tom Abrams retires from FDA after 27 years regulating Rx drug promotions
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance